A lifetime of research may be leading to a life-saving treatment for shock

A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor to prevent multi-organ failure in critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Schönbein. Read more